Crafted as a high-quality dietary supplement, it is easy to incorporate into daily routinesno complicated preparation required, and manufactured to meet standard supplement quality standards.
The same caution applies to combining it with any other GLP-1 or incretin agent: doing so compounds the class effects and the class risks, and there is no documented protocol for it
Needle sizes most commonly used at the RCH include: 25g x 25mm ORANGE 23g x 25mm BLUE 21g x 38mm GREEN Equipment Appropriate size needle for administration Drawing up needle and syringe (if medication not pre-filled) Sharps container Alcohol impregnated swab (if area visibly soiled) Cotton ball Band-Aid (check for allergies) Personal Protective Equipment (PPE) for hazardous medications or infectious patients The procedure Prepare patient and obtain consent Perform the five moments of hand hygiene Prepare equipment as per Aseptic Technique Complete the six rights of medication administration Don PPE if required (particularly for hazardous medications) Draw up or prime medication as per Paediatric Injectable Guidelines Position patient in a safe and comfortable position Procedure Management Guideline Consider the use of comfort techniques such as distraction, buzzy bee, ice or a countdown Landmark injection site (see above) Clean site with an alcohol swab (if required) Stretch the skin flat (Z-tracking if applicable) Inject the needle to the hub at a 90-degree angle Do not aspirate or drawback as this can increase pain and discomfort in children Inject the medication at a slow and steady pace Remove the needle and apply a cotton ball Place the needle in a sharps container Apply Band-Aid Remove PPE (if required) Perform the five moments of hand hygiene Special considerations Monitor for immediate adverse reactions, e.g., fever, rash, vomiting, shortness of breath
facility with human-grade peptides, though lab results arent publicly posted nypost.com
This three-pathway anti-inflammatory profile makes the blend of particular interest for research models where systemic or localized inflammatory signaling is the study endpoint, as investigators can evaluate the combined effect against individual component controls
Morelli et al
